Document is current
Any future updates will be listed below
-
Authors
Roser, Pia
McIntyre, Robert D.
Cremona, Simone
Assiri, Adel
Silva, Lyz Bezerra
Chamseddine, Ghassan
Rubino, Francesco
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 11 February 2025
Revised: 23 April 2025
Accepted: 26 April 2025
First Online: 17 May 2025
Declarations
:
: Francesco Rubino reports receiving research grants from Ethicon (Johnson & Johnson), Novo Nordisk and Medtronic; receiving consulting fees from Morphic Medical; receiving speaking honoraria from Medtronic, Ethicon, Novo Nordisk and Eli Lilly; serving (unpaid) as member of the scientific advisory board for Keyron, Member of DSMB for GI Metabolic Solution Inc, He is President of Metabolic Health Institute (non-profit). None of these relationships and activities have had influence in the conception, execution and reporting of the submitted work. Pia Roser reports receiving speaking honoraria from Novo Nordisk, Rhythm Pharmaceuticals and Boehringer Ingelheim.
